Physicians prescribed Zantac ­— the brand name for generic ranitidine — to millions of people to treat acid reflux, heartburn, and symptoms of peptic ulcers. Ranitidine was once one of the most widely prescribed drugs in the United States.

However, the drug contains a substance that causes cancer in lab animals. People who took Zantac regularly for an extended time could be at risk of developing cancer.

If you were prescribed ranitidine and have since been diagnosed with cancer, a Buda Zantac lawyer could help you explore your legal options. Our attorney has filed many mass torts lawsuits seeking compensation for the victims of Zantac manufacturers and could help you recover your medical expenses, lost income, pain, and suffering.

Consequences of Taking Zantac

In 2019, a laboratory discovered that when ranitidine breaks down in the body, it produces N-nitrosodimethylamine (NDMA), which is a likely human carcinogen. Tests revealed the presence of NDMA in the bodies of Zantac users at higher levels than the Food and Drug Administration (FDA) deems safe.

In response to this research, the FDA recommended in September 2019 for manufacturers to voluntarily recall the drug. By January 2020, most had done so. By April 2020, the FDA requested that manufacturers take ranitidine off the market.

There is evidence linking NDMA to the development of certain cancers in lab animals. Accordingly, there is a suspicion that people who took Zantac for a period of time may be more likely to develop cancer in the:

  • Bladder
  • Stomach
  • Esophagus
  • Colon
  • Rectum
  • Lung


If you or a loved one took Zantac at least once per week, for one year or longer, and received a diagnosis of any of the following cancers after January 2001, consider talking with a lawyer to discuss further options:

  • Prostate
  • Pancreatic
  • Esophageal
  • Stomach/gastric
  • Breast
  • Liver
  • Bladder
  • Colorectal/intestine
  • Kidney
  • Lung (as a non-smoker)

Drug Companies Liable for Dangerous Products

Many lawsuits seeking to hold pharmaceutical manufacturers accountable for producing and distributing dangerous drugs proceed under a strict liability theory. Patients who suffered ill effects do not need to prove that the manufacturers negligently or recklessly distributed a dangerous medication. Instead, they must only show that the drug was dangerous because of a design, manufacturing, or labeling defect.

Additionally, someone who became sick after taking Zantac could proceed on the legal theory of negligence. To win the case, a Zantac attorney would have to prove that the manufacturers were negligent in failing to take reasonable care to discover whether the drug might be dangerous, for example. On the other hand, they might assert that the manufacturers knew the drug was dangerous and tried to hide the information to protect their profits.

In the Buda area, many Zantac cases allege design and label defects. The court might choose to consolidate these cases and use the Multidistrict Litigation (MDL) for mass torts established under 28 United States Code §1407. When a mass tort case proceeds under the MDL rules, all the plaintiffs and defendants combine their pre-trial discovery efforts and evidence-gathering. Meanwhile, the parties attempt to negotiate a global settlement that will result in appropriate compensation for each plaintiff. If there is no agreement by the time a case is ready to go to trial, the individual cases return to their court of origin, and a Buda lawyer could take the Zantac case to trial in a local court.

Work with a Capable Buda Attorney for Your Zantac Claim

If you received a cancer diagnosis after taking ranitidine, you could bring a claim against the manufacturer that produced the drug that harmed you. A compassionate Buda Zantac lawyer is ready to help you pursue your case and get the compensation you deserve. Call to arrange a consultation today.